Cash Flow Statement

Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding

PROCEPT BioRobotics (PRCT) Preferred Shares Issued (2021)

PROCEPT BioRobotics has reported Preferred Shares Issued over the past 1 years, most recently at $85.0 million for Q2 2021.

Quarterly Preferred Shares Issued changed N/A to $85.0 million in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $85.0 million through Dec 2022, changed N/A year-over-year, with the annual reading at $84.7 million for FY2021, 10.75% up from the prior year.
Preferred Shares Issued was $85.0 million for Q2 2021 at PROCEPT BioRobotics.
Over five years, Preferred Shares Issued peaked at $85.0 million in Q2 2021 and troughed at $85.0 million in Q2 2021.